MACOR, PAOLO

MACOR, PAOLO  

Dipartimento di Scienze della Vita  

Settore MED/04 - Patologia Generale  

Docenti di ruolo di IIa fascia  

Mostra records
Risultati 1 - 20 di 69 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autori File
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 1-gen-2014 C. AgostinisDURIGUTTO, PAOLOSBLATTERO, DANIELEBULLA, ROBERTAMACOR, PAOLOTEDESCO, FRANCESCO +
An allosteric redox switch in domain V of β2-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition 1-gen-2021 Macor, Paolo +
Alterations in trabecular bone μ-architecture and cartilages in rats with antigen-induced arthritis (AIA) resulting from synchrotron-based X-ray imaging analysis 1-gen-2016 PACILÈ, SERENABIFFI, STEFANIAMENK, RALF HENDRIKGARROVO, CHIARADAL MONEGO, SIMEONEARFELLI, FULVIARIGON, LUIGICOLOMBO, FEDERICOMACOR, PAOLOACCARDO, AGOSTINOTROMBA, GIULIANA
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 1-gen-2008 MACOR, PAOLOZORZET, SONIACELEGHINI, CLAUDIOTEDESCO, FRANCESCO +
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers 1-gen-2016 MACOR, PAOLO +
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 1-gen-2015 MACOR, PAOLOMEZZAROBA, NELLYZORZET, SONIADURIGUTTO, PAOLOCAPOLLA, SARAMARZARI, ROBERTOTEDESCO, FRANCESCOSBLATTERO, DANIELE +
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. 1-gen-2009 BOSSI, FLEURBULLA, ROBERTAMACOR, PAOLOTEDESCO, FRANCESCO +
Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma. 1-gen-2006 MACOR, PAOLOTEDESCO, FRANCESCO +
Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I 1-gen-2020 Durigutto P.MacOr P.Agostinis C.Bossi F.Grossi C. +
Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 1-gen-2016 MACOR, PAOLODURIGUTTO, PAOLO +
Complement as a biological tool to control tumor growth 1-gen-2018 Macor, PaoloCapolla, SaraTedesco, Francesco
Complement as effector system in cancer immunotherapy. 1-gen-2007 MACOR, PAOLOTEDESCO, FRANCESCO
Complement C1q and C8beta deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. 1-gen-2008 MACOR, PAOLODURIGUTTO, PAOLOBOSSI, FLEURTEDESCO, FRANCESCO +
Complement in human diseases: Lessons from complement deficiencies. 1-gen-2009 MACOR, PAOLOTEDESCO, FRANCESCO +
Complement system and phagocytosis in a colonial protochordate 1-gen-2020 Drago L.Macor P. +
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination 1-gen-2021 Macor P.Manfredi M.De Maso L.Comi G. +
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 1-gen-2005 ZILLER, FEDERICAMACOR, PAOLOBULLA, ROBERTASBLATTERO, DANIELEMARZARI, ROBERTOTEDESCO, FRANCESCO
Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating 1-gen-2015 DURIGUTTO, PAOLOMACOR, PAOLOBULLA, ROBERTATEDESCO, FRANCESCO +
Cubosomes for in vivo fluorescence lifetime imaging 1-gen-2017 BIFFI, STEFANIAANDOLFI, LauraGARROVO, CHIARALORENZON, ANDREAMACOR, PAOLOPRODI, LUCA +
Cubosomes stabilized by a polyphosphoester-analog of Pluronic F127 with reduced cytotoxicity 1-gen-2020 Fornasier M.Biffi S.Macor P. +